Uk Biobank: Consequences for commons and innovation

Science and Public Policy

Volumn 39, Issue 4, 2012, Pages 500-512

  Huzair, Farah ^a   Papaioannou, Theo ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

Anti commons; Biobanks; Commons; Health; Innovation; Public good

Indexed keywords

DRUG DEVELOPMENT; GOVERNANCE APPROACH; HEALTH CARE; INNOVATION; POPULATION GENETICS; PRIVATE SECTOR; PUBLIC GOODS; PUBLIC SECTOR;

EID: 84871360074     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.1093/scipol/scs036     Document Type: Article

References (76)

1. Andrews, L. B. (2005) 'Harnessing the benefits of biobanks', Journal of Law, Medicine and Ethics, Spring: 22-30.
2. Biosot, M. and Canals, A. (2004) 'Data, information and knowledge: Have we got it right?', Journal of Evolutionary Economics, 14: 43-67.
3. Brand, A. M. and Probst-Hensch, N. M. (2007) 'Biobanking for epidemiological research and public health', Pathobiology, 74: 227-38.
4. Buchanan, J. M. (1965) 'An economic theory of clubs', Economics, 32: 1-14.
5. Buchanan, J. M. (1979) 'Notes on the history and direction of public choice'. In: Buchanan, J. M. (ed.) What should Economists do?, pp. 175-82. Indianapolis, IN: Liberty Press.
6. Capps, B., Campbell, A. V. and Meulen, R. (2008) 'Access to the UK biobank resource: Concepts of the public interest and the public good', in Preface and report: Access to the UK Biobank Resource: Concepts of the Public Interest and the Public Good, Commissioned by UK Biobank Ethics and Governance Council. accessed 16 May 2012.
7. Capron, A. M., Mauron, A., Elger, B. S., Baggio, A. et al. (2009) 'Ethical norms and the international governance of genetic databases and biobanks: Findings from an international study', Kennedy Institute of Ethics Journal, 19: 101-24.
8. Chadwick, R. (2001) 'Informed consent and genetic research'. In: Doyal, L. and Tobias, J. S. (eds) Informed Consent in Medical Research, pp. 203-10. London: BMJ Books.
9. Chataway, J., Brusoni, S., Cacciatori, E., Hanlin, R. and Orsenigo, L. (2007) 'The International AIDS Vaccine Initiative (IAVI) in a changing landscape of vaccine development: A public/private partnership as knowledge broker and integrator', European Journal of Development Research, 19/1: 100-17.
10. Chesbrough, H. W. (2003) Open Innovation: The New Imperative for Creating and Profiting from Technology. Boston, MA: Harvard Business School Press.
11. Ciriacy-Wantrup, S. V. and Bishop, R. C. (1975) 'Common property' as a concept in natural resources policy', Natural Resources Journal, 15: 713-27.
12. Cuatrecasas, P. (2006) 'Drug discovery in jeopardy', Journal of Clinical Investigation, 116: 2837-42.
13. David, P. A. (2000) 'A tragedy of the public knowledge 'commons'? Global science, intellectual property and the digital technology boomerang', SIEPR Discussion Paper No. 00-02. Stanford, CA: Stanford Institute for Economic Policy Research. accessed 23 June 2011.
14. Davies, W. and Withers, K. (2006) 'Public innovation. Intellectual property in a digital age'. London: Institute for Public Policy Research. accessed 22 June 2011.
15. Department of Health. (2003) 'Our inheritance, our future: Realising the potential of genetics in the NHS'. accessed 7 April 2011.
16. Department of Trade and Industry. (1998) 'Our competitive future, building the knowledge driven economy'. London: Department of Trade and Industry. accessed 11 April 2011.
17. Department of Trade and Industry. (1999) 'Genome Valley: The economic potential and strategic importance of biotechnology in the UK'. London: Department of Trade and Industry. accessed 11 April 2011.
18. Dickson, M. and Gagnon, J. P. (2004) 'Key factors in the rising cost of new drug discovery and development', Nature Reviews Drug Discovery, 3: 417-29.
19. Economist (2006) 'The birth of philanthrocapitalism', 23 February. accessed 14 February 2012.
20. Edquist, C. (1997) 'Systems of innovation approaches: Their emergence and characteristics'. In: Edquist, C. and Mckelvery, M. (eds) Systems of Innovation; Growth, Competitiveness and Employment, Vol. 1, pp. 1-3. Cheltenham, UK: Edward Elgar.
21. Elger, B. (2010) Ethical Issues of Human Genetic Databases: A Challenge to Classical Health Research Ethics? Farnham, UK: Ashgate.
22. European Commission. (1998) 'Directive 98/44/EC of The European Parliament and of The Council of 6 July 1998 on the legal protection of biotechnological inventions'. accessed 12 April 2011.
23. Foresight Healthcare Panel. (2000) 'Healthcare 2020'. accessed 16 May 2012.
24. Genewatch UK. (2009), Bioscience for life; Appendix; The history of UK Biobank, electronic medical records in the NHS, and the proposal for data-sharing without consent. accessed 12 April 2011.
25. Genewatch UK. (2001) 'Human BioCollections: Who benefits from gene banking', Briefing number 14, April. accessed 10 February 2012.
26. Genewatch UK. (2011) 'Biobanks'. accessed 11 April 2011.
27. Gottweis, H. and Petersen, A. (2008) Governance in Comparative Perspective. Abingdon, UK: Routledge.
28. Grace, C. (2010) 'Product Development Partnerships (PDPs): Lessons from PDPs established to develop new health technologies for neglected diseases'. London: DFID Human Development Resource Centre. accessed 15 February 2012.
29. Hall, M. A., King, N. M. P., Perdue, L. H., Hilner, J. E. et al. (2010) 'Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium', Clinical Trials, 7(1_supplement), S33-S45.
30. Hansjü rgens, B. (2000) 'The influence of Knut Wicksell on Richard Musgrave and James Buchanan', Public Choice, 103: 95-116.
31. Hardin, G. (1968) 'The tragedy of the commons', Science, 162: 1243-8.
32. Heller, M. A. (1998) 'Tragedy of the anticommons: Property in the transition from Marx to markets', Harvard Law Review, 111: 621-88.
33. Heller, M. and Eisenberg, R. (1998) 'Can patents deter innovation? The anticommons in biomedical research', Science, 280: 698-701.
34. Hess, C. and Ostrom, E. (2007) 'Introduction: An overview of the knowledge commons'. In: Hess, C. and Ostrom, E. (eds) Understanding Knowledge as Commons; From Theory to Practice, pp. 3-26. Cambridge MA: MIT Press.
35. Hoeyer, K. (2004) 'The emergence of an entitlement framework for stored tissue -Elements and implications of an escalating conflict in Sweden', Science Studies, 17: 63-82.
36. Kymlicka, W. (1990) Contemporary Political Philosophy. Oxford, UK: Clarendon Press.
37. Lancet. (2009) 'Afternoon at UK Biobank', Lancet, 373: 1146.
38. Langan, M. A. (2007) 'A contemporary history of the origins and development of UK Biobank 1998-2005', University of Glasgow'. accessed 12 February 2012.
39. Lundval, B.-A., ed., (1992) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning. London: Pinter.
40. Musgrave, R. A. (1959) The Theory of Public Finance: A Study in Public Economy. New York: McGraw-Hill.
41. Nelson, R. R., ed., (1993) National Innovation Systems: A Comparative Analysis. Oxford, UK: OUP.
42. Office of the UN High Commissioner for Human Rights. (1976), International Covenant on Economic, Social and Cultural Rights. accessed 12 February 2012.
43. Ohashi, W. and Tanaka, H. (2010) 'Benefits of pharmacogenomics in drug development-Earlier launch of drugs and less adverse events', Journal of Medical Systems, 34: 701-7.
44. Opinion Leader Research. (2003) 'Summary of the UK Biobank Consultation on the Ethics and Governance Framework'. London: Opinion Leader Research.
45. Ostrom, V. and Ostrom, E. (1977) 'Public goods and public choices'. In: Savas, E. S. (ed.) Alternatives for Delivering Public Services: Towards Improved Performance, pp. 7-49. Boulder, CO: Westview Press.
46. Papaioannou, T. (2008) 'Human gene patents and the question of liberal morality', Genomics, Society and Policy, 4: 64-83.
47. Parliamentary Office of Science and Technology (POST). (2002) 'Postnote: The UK Biobank', July (180). accessed 12 April 2011.
48. Parliamentary Office of Science and Technology (POST). (2009) 'Postnote: personalised medicine', April (329). accessed 7 April 2011.
49. Prainsack, B. and Mayrhofer, M. Th. (2009) 'Being a member of the club: the transnational (self-)governance of networks of biobanks', International Journal of Risk Assessment and Management, 12: 64-81.
50. Pathmasiri, S., Deschê nes, M., Joly, Y., Mrejen, T., Hemmings, F. and Knoppers, B. M. (2011) 'Intellectual property rights in publicly funded biobanks: much ado about nothing?', Nature Biotechnology, 29: 319-23.
51. Rose, H. (2001) 'The commodification of bioinformation: the Icelandic Health Sector Database'. London: Wellcome Trust.
52. Rose, H. (2003) 'An ethical dilemma. The rise and fall of UmanGenomics: The model biotech company?', Nature, 425: 123-42.
53. Samuelson, P. A. (1954) 'The pure theory of public expenditure', Review of Economics and Statistics, 23: 387-9.
54. Shapiro, C. (2001) 'Navigating the patent thicket: Cross licenses, patent pools, and standard setting'. In: Jaffe, A. B., Lerner, J. and Stern, S. (eds) Innovation Policy and the Economy, Vol. 1. Cambridge, MA: MIT Press. accessed 14 February 2012.
55. Sleeboom-Faulkner, M. (2009) Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. Abingdon, UK: Routledge.
56. Stiglitz, J. E. (1999) 'Knowledge as a global public good'. In: Kaul, I., Grunberg, I. and Stern, M. A. (eds) Global Public Goods: International Cooperation in the 21st Century, pp. 308-26. Oxford, UK: OUP.
57. Teece, D. J. (1988) 'Capturing value from technological innovation: Integration, Strategic partnering, and licensing decisions', Interfaces, 18/3: 46-61.
58. UK Biobank. (2005) 'UK Biobank press statement', 8 August. accessed 11 April 2011.
59. UK Biobank. (2007a) 'UK Biobank Ethics and Governance Framework'. accessed 11 November 2011.
60. UK Biobank. (2007b) 'UK Biobank: Protocol for a large-scale prospective epidemiological resource'. accessed 11 April 2011.
61. UK Biobank. (2009a) 'Access to the UK Biobank resource: Advising on the public interest and the public good'. accessed 9 February 2012.
62. UK Biobank. (2009b), Further information leaflet. accessed 7 April 2011.
63. UK Biobank. (2010), UK Biobank press statement,7 July. accessed 11 April 2011.
64. UK Biobank. (2011) 'Access and IP'. accessed 11 April 2011.
65. UK Biobank. (2012) 'Biobank UK'. accessed 16 May 2012.
66. UNESCO. (2009), Venice Statement on the Right to Enjoy the Benefits of Scientific Progress and its Applications. accessed 12 February 2012.
67. United Nations. (1948) 'The Universal Declaration of Human Rights'. accessed 9 February 2012.
68. University of Bristol. (2012) 'Avon longitudinal study of parents and children'. accessed 10 February 2012.
69. Webster, A., Brown, N., Douglas, C., Lewis, G. et al. (2008) 'Public attitudes to third party access and benefit sharing: their application to UK Biobank, Final Report'. accessed 9 February 2012.
70. Wicksell, K. (1896) Finanztheoretische Untersuchungen. Jena, Germany: Fischer.
71. Widdows, H. (2009) 'Between the individual and the community: The impact of genetics on ethical models', New Genetics and Society, 28: 173-88.
72. Williams, G. and Schroeder, D. (2004) 'Human genetic banking: Altruism, benefit and consent', New Genetics and Society, 23: 89-103.
73. Winickoff, D. E. and Neumann, L. (2005) 'Towards a social contract for genomics: Property and the public in the 'biotrust' model'. Genomics, Society and Policy, 1: 8-21.
74. WTO. (1994) 'Agreement on Trade-Related Aspects of Intellectual Property Rights'. accessed 16 May 2012.
75. WTO. (2011), accessed 16 May 2012.
76. Zeller, C. (2008) 'From the gene to the globe: Extracting rents based on intellectual property monopolies', Review of International Political Economy, 15: 86-115.